voriconazole has been researched along with Alopecia Cicatrisata in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hisaka, A; Hozuki, S; Sato, H; Shibata, Y; Singh, SP; Tamemoto, Y; Yoshitomo, A | 1 |
Kauffman, CA; Kerr, L; Malani, AN; Obear, J; Singal, B | 1 |
Chandrasekar, PH; Levine, MT | 1 |
1 review(s) available for voriconazole and Alopecia Cicatrisata
Article | Year |
---|---|
Adverse effects of voriconazole: Over a decade of use.
Topics: Adult; Alopecia; Antifungal Agents; Arrhythmias, Cardiac; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Head and Neck Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Nail Diseases; Nervous System Diseases; Periostitis; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Voriconazole | 2016 |
3 other study(ies) available for voriconazole and Alopecia Cicatrisata
Article | Year |
---|---|
Plausible drug interaction between cyclophosphamide and voriconazole via inhibition of CYP2B6.
Topics: Alopecia; Animals; Cyclophosphamide; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Humans; Mice; Neutropenia; Prognosis; Risk Assessment; Voriconazole | 2021 |
Alopecia and nail changes associated with voriconazole therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antifungal Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Male; Methylprednisolone; Michigan; Middle Aged; Mycoses; Nails; Prevalence; Triazoles; Voriconazole | 2014 |
Voriconazole: alopecia and nail changes.
Topics: Alopecia; Antifungal Agents; Humans; Nails; Patient Safety; Risk Assessment; Risk Factors; Time Factors; Voriconazole | 2015 |